{"id":315126,"date":"2026-10-19T09:48:00","date_gmt":"2026-10-19T04:18:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=315126"},"modified":"2026-10-19T09:48:00","modified_gmt":"2026-10-19T04:18:00","slug":"vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/","title":{"rendered":"3 Vaccine Maker, Surfactant and Pizza Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Galaxy Surfactants and Jubilant FoodWorks"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>GSK Pharma Rs 2,566.10, P\/E 40.20. Galaxy Surfactants Rs 2,502.00, P\/E 24.09. Jubilant FoodWorks Rs 417.95, P\/E 62.77. Closing prices of 14 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Vaccine maker, surfactant and pizza chain stocks with the clearest long-term roadmaps today include GSK Pharma in branded medicines and vaccines sold through a large doctor network, Galaxy Surfactants in surfactants and specialty ingredients for personal care and home care brands and Jubilant FoodWorks in Domino&#8217;s Pizza stores across India and neighbouring markets, along with newer food brands. FY26 revenue growth was 1.8% at GSK Pharma, 24.2% at Galaxy Surfactants and 17.2% at Jubilant FoodWorks. P\/E stands at 40.20 for GSK Pharma (industry 37.59), 24.09 for Galaxy Surfactants (industry 36.60) and 62.77 for Jubilant FoodWorks (industry 61.79). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Vaccine maker, surfactant and pizza chain stocks give investors exposure to medicines, personal care ingredients and eating out. Volumes, pricing and margins decide how much of that demand turns into profit.<\/p>\n<p>This list covers three vaccine maker, surfactant and pizza chain stocks: GlaxoSmithKline Pharmaceuticals for branded medicines and vaccines sold through a large doctor network, Galaxy Surfactants for surfactants and specialty ingredients for personal care and home care brands and Jubilant FoodWorks for Domino&#8217;s Pizza stores across India and neighbouring markets, along with newer food brands. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#What_Are_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks\" title=\"What Are Vaccine Maker, Surfactant and Pizza Chain Stocks?\">What Are Vaccine Maker, Surfactant and Pizza Chain Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks_at_a_Glance\" title=\"Vaccine Maker, Surfactant and Pizza Chain Stocks at a Glance\">Vaccine Maker, Surfactant and Pizza Chain Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Why_Do_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Vaccine Maker, Surfactant and Pizza Chain Stocks Have a Strong Roadmap in India?\">Why Do Vaccine Maker, Surfactant and Pizza Chain Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#GlaxoSmithKline_Pharmaceuticals_Branded_Medicines_and_Vaccines_Anchor_the_Roadmap\" title=\"GlaxoSmithKline Pharmaceuticals: Branded Medicines and Vaccines Anchor the Roadmap\">GlaxoSmithKline Pharmaceuticals: Branded Medicines and Vaccines Anchor the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Galaxy_Surfactants_Personal_Care_Ingredients_Anchor_the_Roadmap\" title=\"Galaxy Surfactants: Personal Care Ingredients Anchor the Roadmap\">Galaxy Surfactants: Personal Care Ingredients Anchor the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Jubilant_FoodWorks_Dominos_Store_Network_Anchors_the_Roadmap\" title=\"Jubilant FoodWorks: Domino&#8217;s Store Network Anchors the Roadmap\">Jubilant FoodWorks: Domino&#8217;s Store Network Anchors the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Best_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks_in_India_GSK_Pharma_vs_Galaxy_Surfactants_vs_Jubilant_FoodWorks_on_Key_Financials\" title=\"Best Vaccine Maker, Surfactant and Pizza Chain Stocks in India: GSK Pharma vs Galaxy Surfactants vs Jubilant FoodWorks on Key Financials\">Best Vaccine Maker, Surfactant and Pizza Chain Stocks in India: GSK Pharma vs Galaxy Surfactants vs Jubilant FoodWorks on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#How_to_Evaluate_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Vaccine Maker, Surfactant and Pizza Chain Stocks to Buy Before You Invest\">How to Evaluate Vaccine Maker, Surfactant and Pizza Chain Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Risks_to_Consider_Before_Investing_in_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks\" title=\"Risks to Consider Before Investing in Vaccine Maker, Surfactant and Pizza Chain Stocks\">Risks to Consider Before Investing in Vaccine Maker, Surfactant and Pizza Chain Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#FAQs_on_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks\" title=\"FAQs on Vaccine Maker, Surfactant and Pizza Chain Stocks\">FAQs on Vaccine Maker, Surfactant and Pizza Chain Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Which_are_the_best_vaccine_maker_surfactant_and_pizza_chain_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best vaccine maker, surfactant and pizza chain stocks in India with a strong roadmap?\">Which are the best vaccine maker, surfactant and pizza chain stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Is_GlaxoSmithKline_Pharmaceuticals_a_good_stock_to_buy_now\" title=\"Is GlaxoSmithKline Pharmaceuticals a good stock to buy now?\">Is GlaxoSmithKline Pharmaceuticals a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#What_is_the_PE_ratio_of_GSK_Pharma_Galaxy_Surfactants_and_Jubilant_FoodWorks\" title=\"What is the P\/E ratio of GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks?\">What is the P\/E ratio of GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Which_of_these_vaccine_maker_surfactant_and_pizza_chain_stocks_has_the_highest_return_on_equity\" title=\"Which of these vaccine maker, surfactant and pizza chain stocks has the highest return on equity?\">Which of these vaccine maker, surfactant and pizza chain stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#What_are_the_risks_of_investing_in_vaccine_maker_surfactant_and_pizza_chain_stocks\" title=\"What are the risks of investing in vaccine maker, surfactant and pizza chain stocks?\">What are the risks of investing in vaccine maker, surfactant and pizza chain stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#How_did_GSK_Pharma_Galaxy_Surfactants_and_Jubilant_FoodWorks_perform_in_Q1_FY27\" title=\"How did GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks perform in Q1 FY27?\">How did GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#Do_vaccine_maker_surfactant_and_pizza_chain_stocks_pay_dividends\" title=\"Do vaccine maker, surfactant and pizza chain stocks pay dividends?\">Do vaccine maker, surfactant and pizza chain stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-maker-surfactant-and-pizza-chain-stocks-roadmap-beacon-list\/#How_can_I_invest_in_vaccine_maker_surfactant_and_pizza_chain_stocks_in_India\" title=\"How can I invest in vaccine maker, surfactant and pizza chain stocks in India?\">How can I invest in vaccine maker, surfactant and pizza chain stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks\"><\/span><strong>What Are Vaccine Maker, Surfactant and Pizza Chain Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vaccine maker, surfactant and pizza chain stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks_at_a_Glance\"><\/span><strong>Vaccine Maker, Surfactant and Pizza Chain Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three vaccine maker, surfactant and pizza chain stocks as of the 14 Oct 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">GlaxoSmithKline Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,566.10<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">42,939<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">40.20<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.59<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">45.69%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/galaxysurf\/galaxy-surfactants-ltd-share-price-today\">Galaxy Surfactants<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,502.00<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8,524<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.09<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.60<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.74%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.09<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/jublfood\/jubilant-foodworks-ltd-share-price-today\">Jubilant FoodWorks<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">417.95<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28,248<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.77<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">61.79<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.69%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.14<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare, chemicals and consumer stocks, GSK Pharma trades at a premium to the industry P\/E, while Galaxy Surfactants trades at a discount.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Vaccine Maker, Surfactant and Pizza Chain Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vaccine maker, surfactant and pizza chain stocks have a strong roadmap in India because vaccination demand, personal care brand volumes and more eating out keep adding volumes for these firms. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Vaccination demand:<\/strong> Doctors prescribe more vaccines and branded medicines.<\/li>\n<li><strong>Personal care:<\/strong> Brands buy surfactants for soaps and shampoos.<\/li>\n<li><strong>Eating out:<\/strong> Families order from pizza and food chains.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"GlaxoSmithKline_Pharmaceuticals_Branded_Medicines_and_Vaccines_Anchor_the_Roadmap\"><\/span><strong>GlaxoSmithKline Pharmaceuticals: Branded Medicines and Vaccines Anchor the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>GSK Pharma&#8217;s roadmap rests on branded medicines and vaccines sold through a large doctor network, with established brands supporting steady sales.<\/p>\n<p>Revenue grew from Rs 3,353.80 crore in FY22 to Rs 3,967.03 crore in FY26, an 18.3% rise, and FY26 revenue was 1.8% higher than FY25. FY26 net profit rose 11.7% to Rs 1,035.98 crore. Over four years, net profit rose from Rs 380.77 crore in FY22 to Rs 1,035.98 crore. In Q1 FY27, revenue grew 15.7% to Rs 982.20 crore, and net profit rose 15.7% to Rs 237.18 crore. Operating margin was 38.60% in FY26.<\/p>\n<p>Debt to equity is 0.01 and return on equity is 45.69%. FY26 operating cash flow was Rs 903.30 crore against capital expenditure of Rs 55.28 crore. GSK Pharma paid a dividend of Rs 57 per share for FY26, a yield of 2.25%. At a P\/E of 40.20 against an industry P\/E of 37.59, the stock trades above its industry multiple.<\/p>\n<p>What to watch: The P\/E of 40.20 is a modest premium to the industry P\/E of 37.59, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Galaxy_Surfactants_Personal_Care_Ingredients_Anchor_the_Roadmap\"><\/span><strong>Galaxy Surfactants: Personal Care Ingredients Anchor the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Galaxy Surfactants&#8217; roadmap rests on surfactants and specialty ingredients for personal care and home care brands, with global consumer companies as customers supporting volumes.<\/p>\n<p>Revenue grew from Rs 3,698.22 crore in FY22 to Rs 5,279.92 crore in FY26, a 42.8% rise, and FY26 revenue was 24.2% higher than FY25. FY26 net profit was Rs 267.38 crore. In Q1 FY27, revenue grew 38.5% to Rs 1,785.18 crore. Operating margin was 9.25% in FY26 and 14.17% in Q1 FY27 against 10.57% a year earlier.<\/p>\n<p>Debt to equity is 0.09 and return on equity is 9.74%. FY26 operating cash flow was Rs 332.66 crore against capital expenditure of Rs 136.95 crore. Galaxy Surfactants paid a dividend of Rs 22 per share for FY26, a yield of 0.91%. At a P\/E of 24.09 against an industry P\/E of 36.60, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Q1 FY27 operating margin was 14.17% against 9.25% for FY26, so margin stability is the figure to follow as volumes grow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jubilant_FoodWorks_Dominos_Store_Network_Anchors_the_Roadmap\"><\/span><strong>Jubilant FoodWorks: Domino&#8217;s Store Network Anchors the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Jubilant FoodWorks&#8217; roadmap rests on Domino&#8217;s Pizza stores across India and neighbouring markets, along with newer food brands, with store additions and delivery reach supporting sales.<\/p>\n<p>Revenue grew from Rs 4,437.48 crore in FY22 to Rs 9,586.64 crore in FY26, a 116.0% rise, and FY26 revenue was 17.2% higher than FY25. FY26 net profit rose 54.4% to Rs 386.03 crore. In Q1 FY27, revenue grew 13.6% to Rs 2,588.34 crore, and net profit rose 6.0% to Rs 100.03 crore. Operating margin was 20.96% in FY26 and 20.37% in Q1 FY27 against 20.21% a year earlier.<\/p>\n<p>Debt to equity is 2.14 and return on equity is 18.69%. FY26 operating cash flow was Rs 1,893.55 crore against capital expenditure of Rs 1,009.93 crore. Jubilant FoodWorks paid a dividend of Rs 1.2 per share for FY26, a yield of 0.28%. At a P\/E of 62.77 against an industry P\/E of 61.79, the stock trades in line with its industry multiple.<\/p>\n<p>What to watch: Debt to equity of 2.14 is on the higher side, and net profit margin is only 4.0%, so small cost changes move earnings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks_in_India_GSK_Pharma_vs_Galaxy_Surfactants_vs_Jubilant_FoodWorks_on_Key_Financials\"><\/span><strong>Best Vaccine Maker, Surfactant and Pizza Chain Stocks in India: GSK Pharma vs Galaxy Surfactants vs Jubilant FoodWorks on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best vaccine maker, surfactant and pizza chain stocks in India, GSK Pharma leads on FY26 operating margin and return on equity; Galaxy Surfactants leads on FY26 revenue growth and Q1 FY27 revenue growth; Jubilant FoodWorks ranks second on FY26 revenue growth and FY26 operating margin. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">GSK Pharma<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Galaxy Surfactants<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Jubilant FoodWorks<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,967.03<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,279.92<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,586.64<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,035.98<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">267.38<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">386.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">38.60%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.25%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.96%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">38.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">45.69%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.74%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">40.20<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.09<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.09<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.14<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.25%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.91%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating cash flow (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">903.30<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">332.66<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,893.55<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Vaccine Maker, Surfactant and Pizza Chain Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen vaccine maker, surfactant and pizza chain stocks and shortlist vaccine maker, surfactant and pizza chain stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by company here.<\/li>\n<li>Check revenue growth, operating margin and cash flow together.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these vaccine maker, surfactant and pizza chain stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks\"><\/span><strong>Risks to Consider Before Investing in Vaccine Maker, Surfactant and Pizza Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Debt and cash flow:<\/strong> Jubilant FoodWorks has debt to equity of 2.14.<\/li>\n<li><strong>Consumer demand:<\/strong> Spending patterns can shift sales between quarters.<\/li>\n<li><strong>Input costs:<\/strong> Changes in raw material prices can affect margins.<\/li>\n<li><strong>Quarterly trends:<\/strong> A single weak quarter can change near-term earnings, so track results every quarter.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three healthcare, chemicals and consumer stocks cover vaccines, surfactants and restaurants. GSK Pharma leads on FY26 operating margin and return on equity; Galaxy Surfactants leads on FY26 revenue growth and Q1 FY27 revenue growth; Jubilant FoodWorks ranks second on FY26 revenue growth and FY26 operating margin.<\/p>\n<p>Across vaccine maker, surfactant and pizza chain stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the vaccine maker, surfactant and pizza chain stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Vaccine_Maker_Surfactant_and_Pizza_Chain_Stocks\"><\/span><strong>FAQs on Vaccine Maker, Surfactant and Pizza Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_vaccine_maker_surfactant_and_pizza_chain_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best vaccine maker, surfactant and pizza chain stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GlaxoSmithKline Pharmaceuticals, Galaxy Surfactants and Jubilant FoodWorks stand out for their roadmaps in vaccines, surfactants and restaurants. FY26 revenue growth was 1.8% at GSK Pharma, 24.2% at Galaxy Surfactants and 17.2% at Jubilant FoodWorks, and return on equity ranges from 9.74% to 45.69%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_GlaxoSmithKline_Pharmaceuticals_a_good_stock_to_buy_now\"><\/span><strong>Is GlaxoSmithKline Pharmaceuticals a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GlaxoSmithKline Pharmaceuticals has a debt to equity ratio of 0.01, a return on equity of 45.69% and a P\/E of 40.20 against an industry P\/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_GSK_Pharma_Galaxy_Surfactants_and_Jubilant_FoodWorks\"><\/span><strong>What is the P\/E ratio of GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 40.20 for GSK Pharma (industry 37.59), 24.09 for Galaxy Surfactants (industry 36.60) and 62.77 for Jubilant FoodWorks (industry 61.79). Only GSK Pharma and Jubilant FoodWorks trade at or above the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_vaccine_maker_surfactant_and_pizza_chain_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these vaccine maker, surfactant and pizza chain stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GlaxoSmithKline Pharmaceuticals has the highest return on equity at 45.69%, followed by Jubilant FoodWorks at 18.69% and Galaxy Surfactants at 9.74%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_vaccine_maker_surfactant_and_pizza_chain_stocks\"><\/span><strong>What are the risks of investing in vaccine maker, surfactant and pizza chain stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are debt and cash flow, consumer demand, input costs and quarterly trends. Jubilant FoodWorks has debt to equity of 2.14.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_GSK_Pharma_Galaxy_Surfactants_and_Jubilant_FoodWorks_perform_in_Q1_FY27\"><\/span><strong>How did GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GlaxoSmithKline Pharmaceuticals reported revenue of Rs 982.20 crore, up 15.7% year on year, and net profit rose 15.7% to Rs 237.18 crore. Galaxy Surfactants reported revenue of Rs 1,785.18 crore, up 38.5% year on year. Jubilant FoodWorks reported revenue of Rs 2,588.34 crore, up 13.6% year on year, and net profit rose 6.0% to Rs 100.03 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_vaccine_maker_surfactant_and_pizza_chain_stocks_pay_dividends\"><\/span><strong>Do vaccine maker, surfactant and pizza chain stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, all three companies pay dividends. The dividend yield is 2.25% for GSK Pharma, 0.91% for Galaxy Surfactants and 0.28% for Jubilant FoodWorks, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_vaccine_maker_surfactant_and_pizza_chain_stocks_in_India\"><\/span><strong>How can I invest in vaccine maker, surfactant and pizza chain stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy vaccine maker, surfactant and pizza chain stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best vaccine maker, surfactant and pizza chain stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GlaxoSmithKline Pharmaceuticals, Galaxy Surfactants and Jubilant FoodWorks stand out for their roadmaps in vaccines, surfactants and restaurants. FY26 revenue growth was 1.8% at GSK Pharma, 24.2% at Galaxy Surfactants and 17.2% at Jubilant FoodWorks, and return on equity ranges from 9.74% to 45.69%.\"}},{\"@type\":\"Question\",\"name\":\"Is GlaxoSmithKline Pharmaceuticals a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GlaxoSmithKline Pharmaceuticals has a debt to equity ratio of 0.01, a return on equity of 45.69% and a P\/E of 40.20 against an industry P\/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 40.20 for GSK Pharma (industry 37.59), 24.09 for Galaxy Surfactants (industry 36.60) and 62.77 for Jubilant FoodWorks (industry 61.79). Only GSK Pharma and Jubilant FoodWorks trade at or above the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these vaccine maker, surfactant and pizza chain stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GlaxoSmithKline Pharmaceuticals has the highest return on equity at 45.69%, followed by Jubilant FoodWorks at 18.69% and Galaxy Surfactants at 9.74%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in vaccine maker, surfactant and pizza chain stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are debt and cash flow, consumer demand, input costs and quarterly trends. Jubilant FoodWorks has debt to equity of 2.14.\"}},{\"@type\":\"Question\",\"name\":\"How did GSK Pharma, Galaxy Surfactants and Jubilant FoodWorks perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GlaxoSmithKline Pharmaceuticals reported revenue of Rs 982.20 crore, up 15.7% year on year, and net profit rose 15.7% to Rs 237.18 crore. Galaxy Surfactants reported revenue of Rs 1,785.18 crore, up 38.5% year on year. Jubilant FoodWorks reported revenue of Rs 2,588.34 crore, up 13.6% year on year, and net profit rose 6.0% to Rs 100.03 crore.\"}},{\"@type\":\"Question\",\"name\":\"Do vaccine maker, surfactant and pizza chain stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, all three companies pay dividends. The dividend yield is 2.25% for GSK Pharma, 0.91% for Galaxy Surfactants and 0.28% for Jubilant FoodWorks, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in vaccine maker, surfactant and pizza chain stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy vaccine maker, surfactant and pizza chain stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GlaxoSmithKline Pharmaceuticals, Galaxy Surfactants and Jubilant FoodWorks compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":28,"featured_media":315121,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[7912,11206,7498,13023,13024,12595],"class_list":["post-315126","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-galaxy-surfactants","tag-glaxosmithkline-pharmaceuticals","tag-jubilant-foodworks","tag-surfactant-and-pizza-chain-stocks","tag-surfactant-and-pizza-chain-stocks-to-buy","tag-vaccine-maker"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["315121"],"rank_math_title":["Vaccine Maker, Surfactant and Pizza Chain Stocks"],"rank_math_description":["Vaccine maker, surfactant and pizza chain stocks with a strong roadmap compared on growth, margins, valuation and risks."],"rank_math_focus_keyword":["vaccine maker, surfactant and pizza chain stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-vaccine-maker-surfactant-and-pizza-chain-stocks-with-a-strong-future-roadmap.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/315126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=315126"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/315126\/revisions"}],"predecessor-version":[{"id":315128,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/315126\/revisions\/315128"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/315121"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=315126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=315126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=315126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}